lanly

About Lan Li


Picture Name

About Lan Li

Founded in August 2020, Lanli Bio is a one-stop biomedical integrated institution integrating preclinical efficacy evaluation, in vitro tumor pharmacology, DMPK, Non-GLP toxicology experiments, and pharmacological risk assessment. The team has a wealth of practical experience and successful case experience, will be able to effectively help customers scientifically and reasonably avoid risks. Lanli Bio has advanced scientific research capabilities and research models in the industry, and has advanced biomedical research and development capabilities and technologies, which can integrate technical resources in the industry.

icon icon icon

Preclinical efficacy evaluation

-

icon icon icon

in vitro tumor pharmacology

-

icon icon icon

DMPK

-

icon icon icon

Non-GLP Toxicology Experiment

-

icon icon icon

One-stop medical service

-

rotatex
rotatey
rotatez